11-82914827-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_145018.4(DDIAS):āc.89C>Gā(p.Ser30Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000277 in 1,442,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 33)
Exomes š: 0.0000028 ( 0 hom. )
Consequence
DDIAS
NM_145018.4 missense
NM_145018.4 missense
Scores
6
11
Clinical Significance
Conservation
PhyloP100: 4.64
Genes affected
DDIAS (HGNC:26351): (DNA damage induced apoptosis suppressor) Involved in negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage and regulation of DNA stability. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
PRCP (HGNC:9344): (prolylcarboxypeptidase) This gene encodes a member of the peptidase S28 family of serine exopeptidases. The encoded preproprotein is proteolytically processed to generate the mature lysosomal prolylcarboxypeptidase. This enzyme cleaves C-terminal amino acids linked to proline in peptides such as angiotension II, III and des-Arg9-bradykinin. The cleavage occurs at acidic pH, but the enzyme activity is retained with some substrates at neutral pH. This enzyme has been shown to be an activator of the cell matrix-associated prekallikrein. The importance of angiotension II, one of the substrates of this enzyme, in regulating blood pressure and electrolyte balance suggests that this gene may be related to essential hypertension. A pseudogene of this gene has been identified on chromosome 2. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.38624522).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDIAS | NM_145018.4 | c.89C>G | p.Ser30Cys | missense_variant | 3/6 | ENST00000533655.6 | NP_659455.3 | |
DDIAS | NM_001363481.2 | c.89C>G | p.Ser30Cys | missense_variant | 2/5 | NP_001350410.1 | ||
DDIAS | XM_011544836.3 | c.89C>G | p.Ser30Cys | missense_variant | 2/5 | XP_011543138.1 | ||
DDIAS | XM_024448400.2 | c.89C>G | p.Ser30Cys | missense_variant | 3/6 | XP_024304168.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDIAS | ENST00000533655.6 | c.89C>G | p.Ser30Cys | missense_variant | 3/6 | 1 | NM_145018.4 | ENSP00000435421.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000277 AC: 4AN: 1442678Hom.: 0 Cov.: 29 AF XY: 0.00000139 AC XY: 1AN XY: 718750
GnomAD4 exome
AF:
AC:
4
AN:
1442678
Hom.:
Cov.:
29
AF XY:
AC XY:
1
AN XY:
718750
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2022 | The c.89C>G (p.S30C) alteration is located in exon 3 (coding exon 1) of the DDIAS gene. This alteration results from a C to G substitution at nucleotide position 89, causing the serine (S) at amino acid position 30 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
.;T;.;.;T;.;.;T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;.;D;D;D;D;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
PROVEAN
Uncertain
D;D;D;D;D;D;D;D;D;.
REVEL
Benign
Sift
Uncertain
D;T;D;T;D;T;T;T;T;.
Sift4G
Benign
T;T;D;T;D;D;T;T;T;D
Polyphen
1.0, 0.96
.;.;.;D;D;.;.;.;.;D
Vest4
0.69, 0.79, 0.68, 0.83, 0.83
MutPred
Loss of MoRF binding (P = 0.0858);Loss of MoRF binding (P = 0.0858);Loss of MoRF binding (P = 0.0858);Loss of MoRF binding (P = 0.0858);Loss of MoRF binding (P = 0.0858);.;Loss of MoRF binding (P = 0.0858);Loss of MoRF binding (P = 0.0858);Loss of MoRF binding (P = 0.0858);Loss of MoRF binding (P = 0.0858);
MVP
MPC
0.25
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.